Feds now reviewing prospect of COVID-19 boosters for fully vaccinated people … Cleveland Clinic, Mount Sinai won’t give Aduhelm to patients … FDA chief acknowledges possible missteps on Aduhelm approval...
Becerra orders CMS to rethink $22 Medicare Part B premium price hike tied to Aduhelm
By
Alicia Lasek
Jan 11, 2022
With the 50% price drop of Aduhelm on January 1, there is good reason for CMS to reassess a hefty proposed premium hike for 2022, the U.S. health secretary said. On Wednesday, CMS is expected to announce...